Literature DB >> 6368398

The bactericidal activity in serum and its prognostic clinical value.

J Klastersky.   

Abstract

The determination of the bactericidal activity in serum also gives valuable information on the bacteria, the host and the antibiotics. Clinical studies have proven its value, especially in predicting the outcome of septicemia and other infections. Thus, the bactericidal activity in serum is a useful tool for monitoring therapy. It can also be used as an investigational means for comparing the respective efficacy of antibiotics administered alone or in combination.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6368398     DOI： 10.1007/bf01645296

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


  5 in total

1.  A method of determining the effective therapeutic level in the treatment of subacute bacterial endocarditis with penicillin; a preliminary report.

Authors:  J G SCHLICHTER; H MAC LEAN
Journal:  Am Heart J       Date:  1947-08       Impact factor: 4.749

2.  Synergism between amikacin and cefazolin against Klebsiella: in vitro studies and effect on the bactericidal activity of serum.

Authors:  J Klastersky; F Meunier-Carpentier; J M Prevost; M Staquet
Journal:  J Infect Dis       Date:  1976-09       Impact factor: 5.226

3.  Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections.

Authors:  J Klastersky; D Daneau; G Swings; D Weerts
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

4.  Serum dilution test for bactericidal activity. II. Standardization and correlation with antimicrobial assays and susceptibility tests.

Authors:  L B Reller; C W Stratton
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

Review 5.  Comparative studies of intermittent and continuous administration of aminoglycosides in the treatment of bronchopulmonary infections due to gram-negative bacteria.

Authors:  J Klastersky; J P Thys; G Mombelli
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb
  5 in total
  5 in total

1.  Pharmacodynamic effects of amoxicillin versus cefotaxime against penicillin-susceptible and penicillin-resistant pneumococcal strains: a phase I study.

Authors:  L Aguilar; J Rosendo; I P Balcabao; M Martín; M J Giménez; J Frías; J Prieto
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

2.  Comparative study of serum bactericidal activity of cefotaxime alone or in combination with tobramycin.

Authors:  M G Bergeron; M LeBel; A Charest; J F Forcier; J Morin; F Vallée
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

3.  Serum bactericidal activity of two newer quinolones against Salmonella typhi compared with standard therapeutic regimens.

Authors:  M Trautmann; B Krause; D Birnbaum; J Wagner; V Lenk
Journal:  Eur J Clin Microbiol       Date:  1986-06       Impact factor: 3.267

4.  Crossover assessment of serum bactericidal activity and pharmacokinetics of five broad-spectrum cephalosporins in the elderly.

Authors:  R G Deeter; M P Weinstein; K A Swanson; J S Gross; L C Bailey
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

5.  Bactericidal activity of ciprofloxacin, norfloxacin and ofloxacin in serum and urine after oral administration to healthy volunteers.

Authors:  H J Zeiler; D Beermann; W Wingender; D Förster; P Schacht
Journal:  Infection       Date:  1988       Impact factor: 3.553
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.